News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
382,192 Results
Type
Article (25936)
Company Profile (60)
Press Release (356196)
Multimedia
Podcasts (26)
Webinars (7)
Section
Business (104265)
Career Advice (450)
Deals (16873)
Drug Delivery (51)
Drug Development (47598)
Employer Resources (47)
FDA (12265)
Job Trends (8444)
News (185938)
Policy (19425)
Tag
Academia (1750)
Accelerated approval (3)
Adcomms (8)
Allergies (74)
Alliances (26753)
ALS (57)
Alzheimer's disease (812)
Antibody-drug conjugate (ADC) (56)
Approvals (12327)
Artificial intelligence (172)
Autoimmune disease (10)
Automation (4)
Bankruptcy (142)
Best Places to Work (6894)
BIOSECURE Act (5)
Biosimilars (36)
Biotechnology (40)
Bladder cancer (59)
Brain cancer (17)
Breast cancer (203)
Cancer (1461)
Cardiovascular disease (122)
Career advice (407)
Career pathing (13)
CAR-T (72)
Cell therapy (205)
Cervical cancer (14)
Clinical research (40564)
Collaboration (450)
Compensation (134)
Complete response letters (9)
COVID-19 (1493)
CRISPR (14)
C-suite (147)
Cystic fibrosis (43)
Data (1588)
Decentralized trials (2)
Denatured (18)
Depression (31)
Diabetes (178)
Diagnostics (3528)
Digital health (11)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (52)
Drug pricing (55)
Drug shortages (21)
Duchenne muscular dystrophy (56)
Earnings (37091)
Editorial (22)
Employer branding (6)
Employer resources (44)
Events (51892)
Executive appointments (454)
FDA (13314)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (3)
Funding (410)
Gene editing (40)
Generative AI (10)
Gene therapy (130)
GLP-1 (406)
Government (3038)
Grass and pollen (3)
Guidances (93)
Healthcare (12186)
Huntington's disease (10)
IgA nephropathy (16)
Immunology and inflammation (42)
Indications (19)
Infectious disease (1565)
Inflammatory bowel disease (82)
Inflation Reduction Act (4)
Influenza (27)
Intellectual property (51)
Interviews (40)
IPO (7043)
IRA (19)
Job creations (1840)
Job search strategy (378)
Kidney cancer (7)
Labor market (13)
Layoffs (172)
Leadership (4)
Legal (3632)
Liver cancer (57)
Lung cancer (234)
Lymphoma (100)
Machine learning (4)
Management (17)
Manufacturing (111)
MASH (53)
Medical device (12912)
Medtech (12915)
Mergers & acquisitions (10131)
Metabolic disorders (444)
Multiple sclerosis (55)
NASH (11)
Neurodegenerative disease (49)
Neuropsychiatric disorders (9)
Neuroscience (1151)
NextGen: Class of 2025 (3930)
Non-profit (2823)
Now hiring (17)
Obesity (221)
Opinion (70)
Ovarian cancer (56)
Pain (66)
Pancreatic cancer (56)
Parkinson's disease (90)
Partnered (11)
Patents (117)
Patient recruitment (84)
Peanut (37)
People (34738)
Pharmaceutical (17)
Pharmacy benefit managers (12)
Phase I (11617)
Phase II (17561)
Phase III (14428)
Pipeline (762)
Policy (62)
Postmarket research (1668)
Preclinical (3623)
Press Release (18)
Prostate cancer (77)
Psychedelics (17)
Radiopharmaceuticals (160)
Rare diseases (186)
Real estate (2846)
Recruiting (16)
Regulatory (14232)
Reports (17)
Research institute (1607)
Resumes & cover letters (48)
Rett syndrome (2)
RNA editing (2)
RSV (20)
Schizophrenia (52)
Series A (67)
Series B (50)
Service/supplier (3)
Sickle cell disease (22)
Special edition (4)
Spinal muscular atrophy (102)
Sponsored (13)
Startups (2121)
Stomach cancer (8)
Supply chain (38)
Tariffs (14)
The Weekly (8)
Vaccines (359)
Venture capitalists (13)
Weight loss (141)
Women's health (18)
Worklife (4)
Date
Last 7 days (474)
Last 30 days (1534)
Last 365 days (18239)
2025 (6375)
2024 (19849)
2023 (22737)
2022 (30680)
2021 (32986)
2020 (32191)
2019 (28413)
2018 (21812)
2017 (18906)
2016 (18111)
2015 (21194)
2014 (16023)
2013 (13241)
2012 (14349)
2011 (14622)
2010 (13181)
Location
Africa (354)
Alabama (17)
Alaska (2)
Arizona (119)
Arkansas (10)
Asia (24574)
Australia (3892)
California (3156)
Canada (1248)
China (378)
Colorado (167)
Connecticut (175)
Delaware (122)
Europe (48004)
Florida (562)
Georgia (129)
Idaho (33)
Illinois (364)
India (14)
Indiana (229)
Iowa (3)
Japan (125)
Kansas (74)
Kentucky (12)
Louisiana (8)
Maine (27)
Maryland (646)
Massachusetts (2197)
Michigan (108)
Minnesota (276)
Mississippi (2)
Missouri (52)
Montana (18)
Nebraska (18)
Nevada (35)
New Hampshire (60)
New Jersey (1158)
New Mexico (9)
New York (981)
North Carolina (563)
North Dakota (4)
Northern California (1387)
Ohio (133)
Oklahoma (3)
Oregon (23)
Pennsylvania (851)
Puerto Rico (7)
Rhode Island (24)
South America (520)
South Carolina (23)
Southern California (1214)
Tennessee (79)
Texas (560)
United States (13134)
Utah (115)
Virginia (82)
Washington D.C. (42)
Washington State (231)
West Virginia (3)
Wisconsin (43)
382,192 Results for "allotrope medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Lone Star Bio
Allotrope Medical announces FDA Safer Technologies Program (STeP) designation for their surgical device StimSite
Allotrope Medical™ Inc., a company committed to advancing surgical efficiency and safety, announced that they have received Safer Technologies Program (STeP) designation from the FDA for their surgical device StimSite.
November 7, 2022
·
4 min read
Lone Star Bio
Allotrope Medical Raises $4 Million in Series A Financing
Allotrope Medical Inc., a medical device company whose FDA cleared product StimSite™ helps surgeons locate and identify ureters during pelvic surgery, announced the completion of an oversubscribed $4 million Series A financing.
June 1, 2021
·
2 min read
Allotrope Medical Announces FDA Clearance of StimSite™
Allotrope Medical™ Inc., a company committed to advancing surgical safety and precision, today announced its FDA clearance of their device, StimSite.
November 17, 2020
·
2 min read
Press Releases
Tenon Medical(R) Receives Approval for Notice of Allowance from the European Patent Office
March 11, 2025
·
2 min read
Press Releases
Tenon Medical(R) Announces FDA Clearance of Catamaran(R) SI Joint Fusion System for New Indication to Augment Spinal Fusion
March 24, 2025
·
2 min read
PARADIGM4 UNVEILS NEW ANALYTICAL DEVELOPMENT DATA MANAGEMENT TOOL TO UNLOCK ALLOTROPE DATA FORMAT ‘TREASURE TROVE’
Paradigm4 unveiled its scalable solution for efficiently working with the Allotrope Data Format (ADF) at the Allotrope Foundation’s Spring Connect meeting (19-26th April 2021).
April 27, 2021
·
3 min read
Press Releases
ICU Medical Announces First Quarter 2025 Results
May 9, 2025
·
20 min read
Press Releases
AVITA Medical Reports First Quarter 2025 Financial Results
May 9, 2025
·
11 min read
Press Releases
Trial Finds Inquis Medical’s AVENTUS Thrombectomy System Safe and Effective for Patients with Pulmonary Embolism
May 2, 2025
·
4 min read
Press Releases
Tenon Medical(R) to Host Meetings During the 2025 J.P. Morgan Healthcare Conference in San Francisco
January 9, 2025
·
2 min read
1 of 38,220
Next
